Publisher Correction: Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection (Nature Immunology, (2016), 17, 5, (593-603), 10.1038/ni.3399);Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection

Nature Immunology

Volumn 17, Issue 5, 2016, Pages 593-603

  Beyer, Marc ^a   Abdullah, Zeinab ^b   Chemnitz, Jens M ^c   Maisel, Daniela ^c,m   Sander, Jil ^a   Lehmann, Clara ^c,d   Thabet, Yasser ^a,e   Shinde, Prashant V ^e   Schmidleithner, Lisa ^a   Köhne, Maren ^a   Trebicka, Jonel ^b   Schierwagen, Robert ^b   Hofmann, Andrea ^a   Popov, Alexey ^a   Lang, Karl S ^f   Oxenius, Annette ^g   Buch, Thorsten ^h   Kurts, Christian ^b   Heikenwalder, Mathias ^i,j   Fätkenheuer, Gerd ^c,d   Lang, Philipp A ^e   Hartmann, Pia ^c,d,k   Knolle, Percy A ^b,l   Schultze, Joachim L ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d German Centre for Infection Research (DZIF)   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g ETH ZURICH   (Switzerland)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k UNIVERSITY OF COLOGNE   (Germany)

^l TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^m ROCHE DIAGNOSTICS GMBH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTOME; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CHRONICITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREGULATION; INFECTION CONTROL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; VIRUS INFECTION; VIRUS STRAIN; ADOLESCENT; ADULT; AGED; ANIMAL; C57BL MOUSE; DNA MICROARRAY; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HEK293 CELLS; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOBLOTTING; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84960155205     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/s41590-020-0749-7     Document Type: Erratum

References (50)

1. Rouse, B.T., Sehrawat, S. Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10, 514-526 (2010).
2. McNab, F., Mayer-Barber, K., Sher, A., Wack, A., O'Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87-103 (2015).
3. Hunter, C.A., Jones, S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448-457 (2015).
4. McFadden, G., Mohamed, M.R., Rahman, M.M., Bartee, E. Cytokine determinants of viral tropism. Nat. Rev. Immunol. 9, 645-655 (2009).
5. Deeks, S.G., Tracy, R., Douek, D.C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 39, 633-645 (2013).
6. Crouse, J., Kalinke, U., Oxenius, A. Regulation of antiviral T cell responses by type I interferons. Nat. Rev. Immunol. 15, 231-242 (2015).
7. Wherry, E.J. T cell exhaustion. Nat. Immunol. 12, 492-499 (2011).
8. Kim, P.S., Ahmed, R. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22, 223-230 (2010).
9. Doering, T.A. et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37, 1130-1144 (2012).
10. Wherry, E.J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670-684 (2007).
11. Youngblood, B., Wherry, E.J., Ahmed, R. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr. Opin. HIV AIDS 7, 50-57 (2012).
12. Teijaro, J.R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207-211 (2013).
13. Wilson, E.B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202-207 (2013).
14. Porichis, F., Kaufmann, D.E. HIV-specific CD4 T cells and immune control of viral replication. Curr. Opin. HIV AIDS 6, 174-180 (2011).
15. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
16. Sedaghat, A.R. et al. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. J. Virol. 82, 1870-1883 (2008).
17. Rotger, M. et al. Swiss HIV Cohort Study; Center for HIV/AIDS Vaccine Immunology. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog. 6, e1000781 (2010).
18. Vigneault, F. et al. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J. Virol. 85, 3015-3019 (2011).
19. McKinney, E.F., Lee, J.C., Jayne, D.R., Lyons, P.A., Smith, K.G. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612-616 (2015).
20. Oeckinghaus, A., Hayden, M.S., Ghosh, S. Crosstalk in NF-?B signaling pathways. Nat. Immunol. 12, 695-708 (2011).
21. Prokunina, L. et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32, 666-669 (2002).
22. Salvato, M., Borrow, P., Shimomaye, E., Oldstone, M.B. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65, 1863-1869 (1991).
23. Belnoue, E., Fontannaz-Bozzotti, P., Grillet, S., Lambert, P.H., Siegrist, C.A. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. J. Virol. 81, 7338-7350 (2007).
24. Doyle, L.B., Doyle, M.V., Oldstone, M.B. Susceptibility of newborn mice with H-2k backgrounds to lymphocytic choriomeningitis virus infection. Immunology 40, 589-596 (1980).
25. Crawford, A. et al. Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity 40, 289-302 (2014).
26. Graham, C.M., Christensen, J.R., Thomas, D.B. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma? Immunology 121, 238-247 (2007).
27. Ruan, H., Pownall, H.J., Lodish, H.F. Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-?B. J. Biol. Chem. 278, 28181-28192 (2003).
28. Sasaki, Y. et al. Canonical NF-?B activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729-739 (2006).
29. Sledzińska, A. et al. TGF-β signalling is required for CD4+ T cell homeostasis but dispensable for regulatory T cell function. PLoS Biol. 11, e1001674 (2013).
30. Speiser, D.E. et al. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat. Rev. Immunol. 14, 768-774 (2014).
31. Yi, J.S., Du, M., Zajac, A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324, 1572-1576 (2009).
32. Fröhlich, A. et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324, 1576-1580 (2009).
33. Elsaesser, H., Sauer, K., Brooks, D.G. IL-21 is required to control chronic viral infection. Science 324, 1569-1572 (2009).
34. Nokta, M., Rossero, R., Loesch, K., Pollard, R.B. Kinetics of tumor necrosis factor ? and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. AIDS Res. Hum. Retroviruses 13, 1633-1638 (1997).
35. De Pablo-Bernal, R.S. et al. TNF-α levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects. J. Antimicrob. Chemother. 69, 3041-3046 (2014).
36. Aukrust, P. et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J. Infect. Dis. 179, 74-82 (1999).
37. Aukrust, P. et al. Serum levels of tumor necrosis factor-α (TNF ?) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169, 420-424 (1994).
38. Aukrust, P. et al. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-α activity in human immunodeficiency virus type 1 infection. J. Infect. Dis. 176, 913-923 (1997).
39. Sade-Feldman, M. et al. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38, 541-554 (2013).
40. Keir, M.E., Butte, M.J., Freeman, G.J., Sharpe, A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704 (2008).
41. Han, S., Asoyan, A., Rabenstein, H., Nakano, N., Obst, R. Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery. Proc. Natl. Acad. Sci. USA 107, 20453-20458 (2010).
42. Planès, R. et al. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor ?-and toll-like receptor 4-mediated mechanisms. J. Virol. 88, 6672-6689 (2014).
43. Cepeda, E.J., Williams, F.M., Ishimori, M.L., Weisman, M.H., Reveille, J.D. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann. Rheum. Dis. 67, 710-712 (2008).
44. Brunasso, A.M.G., Puntoni, M., Gulia, A., Massone, C. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. Rheumatology 50, 1700-1711 (2011).
45. Kim, S.Y., Solomon, D.H. Tumor necrosis factor blockade and the risk of viral infection. Nat. Rev. Rheumatol. 6, 165-174 (2010).
46. Habib, S.F., Hasan, M.Z., Salam, I. Infliximab therapy for HIV positive Crohn's disease: A case report. J. Crohns Colitis 3, 302-304 (2009).
47. Chemnitz, J.M. et al. RNA fingerprints provide direct evidence for the inhibitory role of TGF? and PD-1 on CD4+ T cells in Hodgkin lymphoma. Blood 110, 3226-3233 (2007).
48. Beyer, M. et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat. Immunol. 12, 898-907 (2011).
49. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M., Oldstone, M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521-540 (1984).
50. Lang, P.A. et al. Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell Death Differ. 20, 649-658 (2013).